FDA Approves First Once-Weekly Insulin Shot for Type 2 Diabetes, Offering Major Relief from Daily Injections

The U.S. Food and Drug Administration has approved Awiqli (insulin icodec-abae), the first once-weekly basal insulin for adults with type